Ardsley Advisory Partners’s BioAmber Inc. BIOA Stock Holding History

Ardsley Advisory Partners’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-50,000	Closed	-$149K	–	221
2016 Q2	$149K	Hold	50,000	–	–	0.03%	137
2016 Q1	$210K	Hold	50,000	–	–	0.03%	117
2015 Q4	$309K	Hold	50,000	–	–	0.04%	106
2015 Q3	$268K	Sell	50,000 -40,000	-44%	-$264K	0.07%	108
2015 Q2	$774K	Buy	+90,000	New	+$823K	0.1%	90

Other funds holding BIOA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ardsley Advisory Partners's BIOA Position: Q3 2016 in Review

Ardsley Advisory Partners sold out of BioAmber Inc. (BIOA) in Q3 2016, closing a stake of 50,000 shares — an estimated $149K sold.

Ardsley Advisory Partners first reported a position in BIOA in Q2 2015 and held it in 5 quarters. The position peaked at $774K in Q2 2015. 33 funds tracked by Wall St. Rank hold BIOA as of Q3 2016.

Ardsley Advisory Partners reported no remaining BioAmber Inc. position as of Q3 2016 after selling out during the quarter.
Ardsley Advisory Partners sold 50,000 BioAmber Inc. shares in Q3 2016, an estimated $149K.
Ardsley Advisory Partners first reported a position in BioAmber Inc. in Q2 2015 and held it in 5 quarters.
Ardsley Advisory Partners's BioAmber Inc. position peaked at $774K in Q2 2015.
33 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2016.

Based on Ardsley Advisory Partners's 13F filing for Q3 2016, filed 14 Nov 2016.